Dr. Michael Wagner covers the basics of epithelioid hemangioendothelioma, a rare vascular cancer, spanning symptoms, ...

Most pathologists say Grade Group 1 looks like cancer, but many urologists say the lesions do not act like a malignancy because they tend not to spread or kill. The authors of the white paper ...

Cancer research no longer moves slowly; it advances rapidly. Revolutionary discoveries in precision medicine, immunotherapy, and gene editing emerge almost weekly, yet many patients still confront ...

Key Takeaways Small lymphocytic lymphoma is an indolent, incurable disease, characterized by slow progression and requiring long-term management. The patient found purpose in teaching, writing, and ...

After transformation, survival rates varied by original cancer type, with the poorest prognosis for those transformed from CLL/SLL and from LPL/WM.

Most prostate cancer is so slow-growing that it is likely never to bother a man until he dies from something else. So, we don’t want to operate on these relatively indolent cancers because there ...

Dr. Maurie Markman comments on a study in Clinical Cancer Research suggesting that low levels of phosphorylated EGFR in prostate tissue can predict a more favorable course of disease.

Differentiated thyroid carcinoma (DTC) is typically indolent, and some patients may be managed conservatively without ...